- 询价
- 西格
- XGK1725
- 进口、国产
- 2025年07月11日
- WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 详见说明书
- 详见说明书
7 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
上海西格
- 库存：
42
- 靶点：
详见说明书
- 级别：
详见说明书
- 目录编号：
详见说明书
- 克隆性：
多克隆
- 抗原来源：
Rabbit
- 保质期：
详见说明书
- 抗体英文名：
Anti-phospho-GSK-3 Beta(Ser21+Ser29)
- 抗体名：
磷酸化糖原合酶激酶3β抗体
- 标记物：
详见说明书
- 宿主：
详见说明书
- 适应物种：
详见说明书
- 免疫原：
KLH conjugated Synthesised phosphopeptide derived from human GSK-3 Beta around the phosphorylation site of Ser21+Ser29
- 亚型：
IgG
- 形态：
详见说明书
- 应用范围：
WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
- 浓度：
1mg/1ml
- 保存条件：
详见说明书
- 规格：
0.1ml/100μg 0.2ml/200μg
| 产品名称 | 磷酸化糖原合酶激酶3β抗体 |
| 英文名称 | Anti-phospho-GSK-3 Beta(Ser21+Ser29)抗体 |
| 货号 | XGK1725 |
中文名称 磷酸化糖原合酶激酶3β抗体
别 名 GSK3B(Phospho-Ser21+Ser29); GSK3B(Phospho-S21+S29); p-GSK-3 Beta(Ser21+Ser29); p-GSK-3 beta(S21+S29); Glycogen synthase kinase 3 beta; GSK 3 beta; GSK 3B; GSK3B; GSK3B protein; GSK3beta isoform; GSK3 beta; Glycogen synthase kinase-3 beta; GSK-3 beta; GSK3B_HUMAN.
浓 度 1mg/1ml
规 格 0.1ml/100μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Sheep, Guinea Pig
产品类型 一抗 磷酸化抗体
研究领域 肿瘤 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 46kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human GSK-3 Beta around the phosphorylation site of Ser21+Ser29
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Glycogen synthase kinase 3 (GSK3) is a proline directed serine threonine kinase that was initially identified as a phosphorylating and inactivating glycogen synthase. GSK3 has been implicated in fundamental cell processes such as cell fate determination, metabolism, transcriptional control and oncogenesis. Two isoforms, alpha (GSK3A; OMIM 606784) and beta, show a high degree of amino acid homology within their catalytic domains. GSK3B is involved in energy metabolism, neuronal cell development and body pattern formation.
Function : Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity.
Subunit : Monomer. Interacts with ARRB2 and DISC1. Interacts with CABYR, MMP2, MUC1, NIN and PRUNE Interacts with AXIN1; the interaction mediates hyperphosphorylation of CTNNB1 leading to its ubiquitination and destruction. Interacts with and phosphorylates SNAI1. Interacts with DNM1L (via a C-terminal domain). Found in a complex composed of MACF1, APC, AXIN1, CTNNB1 and GSK3B.
Subcellular Location : Cytoplasm. Nucleus. Cell membrane. Note=The phosphorylated form shows localization to cytoplasm and cell membrane. The MEMO1-RHOA-DIAPH1 signaling pathway controls localization of the phosophorylated form to the cell membrane.
Tissue Specificity : Expressed in testis, thymus, prostate and ovary and weakly expressed in lung, brain and kidney.
Post-translational modifications : Phosphorylated by AKT1 and ILK1. Upon insulin-mediated signaling, the activated PKB/AKT1 protein kinase phosphorylates and desactivates GSK3B, resulting in the dephosphorylation and activation of GYS1. Activated by phosphorylation at Tyr-216.
Similarity : Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. GSK-3 subfamily.
实验原理 :
（1）特异性结合抗原：抗体本身不能直接溶解或杀伤带有特异抗原的靶细胞，通常需要补体或吞噬细胞等共同发挥效应以清除病原微生物或导致病理损伤。然而，抗体可通过与病毒或毒素的特异性结合，直接发挥中和病毒的作用。
（2）活补体：IgM、IgG1、IgG2和IgG3可通过经典途径激活补体，凝聚的IgA、IgG4和IgE可通过替代途径激活补体。
（3）结合细胞：不同类别的免疫球蛋白，可结合不同种的细胞，参与免疫应答。
（4）可通过胎盘及粘膜：免疫球蛋白G（IgG）能通过胎盘进入胎儿血流中，使胎儿形成自然被动
免疫。免疫球蛋白A（IgA）可通过消化道及呼吸道粘膜，是粘膜局部抗感染免疫的主要因素。
（5）具有抗原性：抗体分子是一种蛋白质，也具有刺机体产生免疫应答的性能。不同的免疫球蛋白分子，各具有不同的抗原性。
（6）抗体对理化因子的抵抗力与一般球蛋白相同：不耐热，60～70℃即被破坏。各种酶及能使蛋白质凝固变性的物质，均能破坏抗体的作用。抗体可被中性盐类沉淀。在上常可用硫酸铵或硫酸钠从免疫血清中沉淀出含有抗体的球蛋白，再经透析法将其纯化。
抗体制备过程：
1.材料与试剂
a．提取的动物 Ig
b．弗氏完全佐剂和弗氏不完全佐剂
c．青霉素和链霉素
d．实验动物 兔
e．其它材料及试剂
2、选择实验活体。
3、进行动物免疫实验。
4、试取血样进行测试，查看免疫效果。
5、如果免疫成功，杀死实验活体，采集全部血清。
6、纯化出抗体。
7、鉴定抗体。胎牛血清（无菌采制）
我司提供以下技术外包服务:
1. Anti-phospho-GSK-3 Beta(Ser21+Ser29)抗体分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等
2.蛋白工程：原核、哺乳动物蛋白表达系统等
3.病毒包装：腺病毒、慢病毒等
4.抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
5.细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
抗体的鉴定：
1）抗体的效价鉴定：鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。
2）抗体的特异性鉴定：抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。
3）真核翻译起始因子2C2抗体的亲和力：是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。
Anti-Phospho-MSK1 (Thr581) /FITC 荧光素标记0酸化有丝分裂原和应激活化型蛋白激酶1抗体IgGMulti-class antibodies规格： 0.2ml
Anti-TNK1/FITC 荧光素标记非受体型酪氨酸蛋白激酶Tnk1抗体IgGMulti-class antibodies规格： 0.2ml
5-羟色胺抗体 Anti-5-HT 0.1ml
Mouse Anti-Rabbit IgM/Cy5.5 Cy5.5标记的小鼠抗兔IgM 0.1ml
GDAP1 英文名称： 神经节苷脂诱导分化相关蛋白1抗体 0.2ml
Rhesus antibody Rh PSD95 突触后密度蛋白95抗体 规格 0.1ml
Anti-TNK1/FITC 荧光素标记非受体型酪氨酸蛋白激酶Tnk1抗体IgGMulti-class antibodies规格： 0.2ml
Anti-MTL/FITC 荧光素标记胃动素抗体IgGMulti-class antibodies规格： 0.2ml
Anti-UCN/FITC 荧光素标记新型血管活性因子UCN抗体(人)IgGMulti-class antibodies规格： 0.2ml
α-1抗胰蛋白酶抗体 Anti-AAT 0.2ml
Mouse Anti-rabbit IgG/Gold 胶体金标记的小鼠抗兔IgG 0.5ml
GFOD2 英文名称： 葡萄糖果糖还原酶2抗体 0.2ml
Rhesus antibody Rh PSA(PA5) 鼠抗人前列腺特异性抗原单克隆抗体(检测) 规格 0.1ml
Anti-UCN/FITC 荧光素标记新型血管活性因子UCN抗体(人)IgGMulti-class antibodies规格： 0.2ml
VEGFR-3/Flt-4(Human Vascuoar endothelial cell growth factor receptor 2) ELISA kit 人血管内皮细胞生长因子受体3Multi-class antibodies规格： 48T
Anti-GFP 绿色荧光蛋白抗体Multi-class antibodies规格： 0.2ml
Rhesus antibody Rh Mouse Anti-Guinea pig IgG/Alexa Fluor 647 Alexa Fluor 647标记的小鼠抗豚鼠IgG 规格 0.1ml
HSP-70(Human Heat Shock Protein 70) ELISA Kit 人热休克蛋白70 96T
Robo2 英文名称： 轴突导向受体蛋白2抗体 0.1ml
phospho-CFL1 (Tyr89) 英文名称： 0酸化丝切蛋白抗体 0.1ml
Anti-GFP 绿色荧光蛋白抗体Multi-class antibodies规格： 0.2ml
无菌病毒运输液(VTM)3ml*36用于甲流病毒标本运送
Oxford Listeria selective supplement 牛津李斯特氏菌选择添加剂 1.07006.001 MERCK默克 incubation media Oxford Listeria selective supplement 牛津李斯特氏菌选择添加剂 1.07006.001 MERCK默克
布氏肉汤 250g 用于空肠弯曲菌培养及运动性观察。(GB、ISO)
人脐血间质干细胞完全培养基Humanumbilicalcordbloodmesenchymalstemcellsculturemedium
磺胺嘧啶溶液 1ml*5 每支添加于100mlHB0256中
Anti-phospho-GSK-3 Beta(Ser21+Ser29)抗体GlucoseTryptoneAgar
脆弱拟杆菌活化培养基肉汤 250g 用于脆弱拟杆菌活化培养
BETA-SSA 琼脂 BETA-SSA Agar 250 用于链球菌的选择性分离培养(ACUMEDIA方法)
志贺氏菌增菌肉汤基础250g/瓶用于志贺氏菌的选择性增菌(ISO)，每添加0.05mg新生霉素incubationmedia志贺氏菌增菌肉汤基础250g/瓶用于志贺氏菌的选择性增菌(ISO)，每添加0.05mg新生霉素
TSA培养基平板(9cm) 10个/包 用于环境、器皿、设备和表面的无菌检测
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
的关系理不出头绪。GSK-3 beta 总蛋白减少，p-GSK-3 beta (ser 9)增加，是不是足以说明有活性的GSK-3 beta 减少更多，这样理解不知道对不对，希望给以指点。 galaxy22 楼主你好，请问你做出结果的tyr216的抗体是哪个公司的。。。我做出来总量是减少的，active B catenin是减少的，那我有必要做ser9 和tyr216的磷酸化形式吗？我想研究wnt和akt。。。 棉花糖的温柔
【求助】于NF-KB 激活，P65磷酸化位点是ser536还是ser276?
伽利略 ............................... chenlydd 两者都有,蛋白磷酸化水平与其功能密切相关：检测其磷酸化水平可用抗磷酸化位点抗体检测。www.cellsignal.com公司有相应抗体出售。 P65磷酸化位点: regulates apoptosis: S536‑p regulates cell growth: S536‑p regulates cell
of the serine/threonine kinaseAkt, which will phosphorylate GSK-3 at specific serine residues(Ser21 in GSK-3a and Ser9 in GSK-3b), leading to the inactivationof GSK-3 kinase activity (10) . However, this phosphorylationand inactivation of GSK-3 by Akt
技术资料暂无技术资料 索取技术资料
Anti-phospho-GSK-3 Beta(Ser21+Ser29)抗体
询价
